The groundbreaking success of Viagra, developed by copyright, undeniably revolutionized the approach of erectile dysfunction , and ignited a massive boom in the pharmaceutical sector. However, now, investing in firms reliant on aging blockbuster drugs like Viagra presents a challenging landscape.